CollPlant Biotechnologies Ltd.
CLGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $41,235 | $72,777 | $92,128 | $163,092 |
| - Cash | $11,909 | $26,674 | $29,653 | $13,148 |
| + Debt | $3,081 | $3,159 | $2,911 | $3,608 |
| Enterprise Value | $32,407 | $49,262 | $65,386 | $153,552 |
| Revenue | $515 | $10,959 | $299 | $15,641 |
| % Growth | -95.3% | 3,565.2% | -98.1% | – |
| Gross Profit | -$2,148 | $7,866 | -$1,177 | $13,636 |
| % Margin | -417.1% | 71.8% | -393.6% | 87.2% |
| EBITDA | -$15,554 | -$5,907 | -$15,815 | $1,047 |
| % Margin | -3,020.2% | -53.9% | -5,289.3% | 6.7% |
| Net Income | -$16,609 | -$7,019 | -$16,925 | $237 |
| % Margin | -3,225% | -64% | -5,660.5% | 1.5% |
| EPS Diluted | -1.45 | -0.62 | -1.52 | 0.034 |
| % Growth | -133.9% | 59.2% | -4,544.4% | – |
| Operating Cash Flow | -$14,093 | -$2,763 | -$13,698 | $2,501 |
| Capital Expenditures | -$483 | -$954 | -$1,274 | -$1,428 |
| Free Cash Flow | -$14,576 | -$3,717 | -$14,972 | $1,073 |